The closure of Fantastic Pixel Castle marks another casualty in NetEase’s global retreat. Former WoW veteran Greg Street’s ambitious project Ghost couldn’t secure funding despite public development transparency.
Electronic Arts’ historic $55 billion sale to Saudi Arabia’s Public Investment Fund raises critical questions about talent retention, creative control, and the future of gaming’s most inclusive studios. The deal represents the largest leveraged buyout in history across any industry.
Cybersecurity researchers have identified thousands of malicious domains targeting job seekers during economic uncertainty. The schemes have evolved to include sophisticated deepfake technology and malware-laced resumes.
Goldman Sachs has updated its conviction list with five stocks projected to deliver over 70% upside. The picks span AI chips, hydrogen energy, and gaming, but face significant execution risks in volatile markets.
Palantir’s explosive quarterly results and upgraded guidance showcase the power of its AI pivot. Yet beneath the impressive numbers lies a complex story of government dependency and valuation concerns that could define its future trajectory.
Palantir CEO Alex Karp’s declaration of his company as “completely anti-woke” comes alongside explosive financial growth. But what does this political positioning mean for the defense tech giant’s market position and competitive strategy?
AAR’s strategic acquisition of HAECO Americas for $78 million addresses critical MRO capacity shortages while securing $850M in customer contracts. This move signals broader industry consolidation as maintenance providers scramble to meet unprecedented demand.
A sophisticated criminal alliance is targeting the logistics industry through digital infiltration and real-world theft. Cybercriminals compromise freight companies using legitimate remote access tools, then coordinate with organized crime to redirect and steal high-value shipments worth millions.
Eli Lilly is making a massive $3 billion strategic investment in European pharmaceutical manufacturing. The new Dutch facility represents a major shift in how blockbuster drugs like GLP-1 agonists will be produced and distributed globally.
A Tennessee explosives factory tragedy that killed 16 workers highlights manufacturing’s ongoing safety challenges. Meanwhile, Rivian’s layoffs and worker-led factory revival show the industry’s contrasting fortunes.
